J Transl Med. 2018 Oct 22;16(1):288. doi: 10.1186/s12967-018-1649-6.

A modified method for isolation of human cardiomyocytes to model cardiac diseases.

Guo GR^1,2, Chen L², Rao M², Chen K², Song JP³, Hu SS⁴.

Abstract

BACKGROUND:

Cardiomyocytes derived from animals and induced pluripotent stem cells (iPSCs) are two main cellular models to study cardiovascular diseases, however, neither provides precise modeling of the response of mature human cardiomyocytes to disease or stress conditions. Therefore, there are emerging needs for finding an optimized primary human cardiomyocytes isolation method to provide a bona fide cellular model.

METHODS AND RESULTS:

Previous established protocols for the isolation of primary human cardiomyocytes are limited in their application due to relatively low cell yield and the requirement of tissue integrity. Here, we developed a novel, simplified method to isolate human cardiomyocytes robustly with improved viability from tissue slicing. Isolated cardiomyocytes showed intact morphology, retained contractility, ion flux, calcium handling, and responses to neurohormonal stimulation. In addition, we assessed the metabolic status of cardiomyocytes from different health conditions.

CONCLUSION:

We present a novel, simplified method for isolation of viable cardiomyocytes from human tissue.